🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Clinical Trials in the USA / NCT07619729
Enrolling by invitation Phase 4

Evaluate the Efficacy of an Oral Health Behavioral Intervention in People With Diabetes

NCT07619729 · tracked via the Priya Life Science USA tracker
Sponsor
Colgate Palmolive
Phase
Phase 4
Started
2026-05-26
Last updated
2026-09-03

Condition(s) studied

Diabetes Type 2Periodontal DiseaseCaries

Investigational drug(s) / intervention(s)

Diabetes Oral Health ProgramStannous Fluoride Dentifrice →Cetylpyridinium Chloride (CPC) and Zinc Lactate Mouthwash

Diabetes Oral Health Program: All subjects will receive a behavioral intervention through text messages with links to educational pages about oral health or diabetes. Subjects will have the option of selecting in to the product intervention.

Stannous Fluoride Dentifrice: This is an opt-in product intervention, and it is expected that not all subjects will opt-in. Subjects will need to re-order the product every 3 months. All subjects who order product will receive a toothbrush, toothpaste, and mouthwash.

Cetylpyridinium Chloride (CPC) and Zinc Lactate Mouthwash: This is an opt-in product intervention, and it is expected that not all subjects will opt-in. Subjects will need to re-order the product every 3 months. All subjects who order product will receive a toothbrush, toothpaste, and mouthwash.

Study summary

The purpose of this clinical study is to evaluate the effect of a behavioral intervention on the number of preventive and treatment dental claims in a population of people with Type 2 Diabetes.

Eligibility

Sex
ALL
Min age
18 Years
Max age
Healthy volunteers
No
Inclusion Criteria: * Consented to participation in the Fidelis Care Diabetes Care program. * Aged 18 years and older * English speaking. * Willing and able to receive text messages, and participate in online activities for the duration of the program. * Diagnosis of Type 2 Diabetes. Exclusion Criteria: * Severe cognitive impairment. * General anesthesia in the past 3 months. * Type 1 diabetes. * Self-reported pregnant.

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
Decentralized Site - Virtual/Remote (NY, USA) Long Island City New York

More Colgate Palmolive trials in the USA

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07619729 on ClinicalTrials.gov ↗ ← All trials in the USA